ANDA 202651, held by Hikma Farmaceutica. Diltiazem Hydrochloride.
As of Nov 16, 2026, ANDA 202651 (Diltiazem Hydrochloride), held by Hikma Farmaceutica, was first approved by FDA on Aug 9, 2012, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 9, 2012 | Original application | Approved |
| Diltiazem Hydrochloride5MG/ML · injectable;injection | Diltiazem Hydrochloride | Discontinued |
| Diltiazem Hydrochloride50MG/10ML · injectable; injection | Diltiazem Hydrochloride | Rx |
| Diltiazem Hydrochloride125MG/25ML · injectable; injection | Diltiazem Hydrochloride | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters